USA – Biomea Fusion, a preclinical-stage biopharmaceutical company focused on the discovery and development of irreversible small molecules to treat patients with genetically defined cancers, announced the appointment of Franco Valle as Chief Financial Officer. Mr. Valle is an accomplished financial expert who brings extensive experiences to Biomea, in particular with building the necessary infrastructure to support clinical and operational growth within biotech companies. He will assume the financial leadership from Sunny Lee who has served at that role since September2020. Recently, Mr. Valle served as Principal Accounting Officer &…
Read MoreFranco Valle appointed chief financial officer at Biomea fusion in move to strengthen company’s executive team
